BioSpace News Archive

Microbot Medical Inc. has concluded 2020 with the achievement of several operating and developmental milestones.

Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in clinical research, launched as an independent company following the strategic separation of the Parexel Informatics business from Parexel International.

Hearing loops, also called induction loops for audio frequency, provide a realistic and usually cost-effective solution to significantly enhance the signal-to-noise ratio and comprehension of speech.

Bulimia nervosa refers to a type of eating disorder linked with binge eating following compensatory processes.

The expansion of the global neurothrombectomy devices market is estimated to be driven by increasing cases of acute ischemic stroke across the globe.

Ultimovacs ASA, announced its participation in the Phase II DOVACC collaboration study with the Nordic Society of Gynaecological Oncology – Clinical Trial Unit, the European Network of Gynaecological Oncological Trial Groups and AstraZeneca, to conduct a randomized Phase II clinical trial to evaluate Ultimovacs’ proprietary universal cancer vaccine, UV1, in combination with AstraZeneca’s durvalumab and olaparib in patients with relapsed ovarian cancer.

Eurofins GeneScan Technologies announces that the VIRSeek SARS-CoV-2 Solution has been evaluated and approved by the AOAC Performance Tested MethodsSM Program on December 29, 2020 and awarded Emergency Response Validation PTM certification number 122006.

VALBIOTIS, a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces its participation in the prestigious ‘J.P. Morgan Healthcare’ annual conference, taking place from 11 to 14 January 2021, in virtual format.

Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, announced a business update for the fourth quarter 2020 and certain preliminary, unaudited key financials for its financial year 2020.

Veristat, a scientific-minded global clinical research organization, announced the launch of business operations in Spain and the appointment of Montserrat Barceló Riera, M.D. as Vice President, Europe.